Build Your Comparison

Side-by-side financial analysis
EQ logo
EQ
KMDA logo
KMDA
JPM logo
JPM
KO logo
KO
Try popular comparisons:

Stock Comparison

EQ vs KMDA vs JPM vs KO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
EQ
Equillium, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$271M
5Y Perf.-4.7%
KMDA
Kamada Ltd.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • IL
Market Cap$429M
5Y Perf.-4.1%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+241.0%
KO
The Coca-Cola Company

Beverages - Non-Alcoholic

Consumer DefensiveNYSE • US
Market Cap$355.61B
5Y Perf.+84.9%

EQ vs KMDA vs JPM vs KO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
EQ logoEQ
KMDA logoKMDA
JPM logoJPM
KO logoKO
IndustryBiotechnologyDrug Manufacturers - Specialty & GenericBanks - DiversifiedBeverages - Non-Alcoholic
Market Cap$271M$429M$896.00B$355.61B
Revenue (TTM)$0.00$182M$280.33B$49.28B
Net Income (TTM)$-19M$20M$57.05B$13.70B
Gross Margin41.2%60.0%61.7%
Operating Margin14.0%25.9%29.3%
Forward P/E17.4x14.4x25.3x
Total Debt$719K$12M$942.38B$45.49B
Cash & Equiv.$30M$75M$343.34B$10.27B

EQ vs KMDA vs JPM vs KOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

EQ
KMDA
JPM
KO
StockJun 20Jun 26Return
Equillium, Inc. (EQ)10095.3-4.7%
Kamada Ltd. (KMDA)10095.9-4.1%
JPMorgan Chase & Co. (JPM)100341.0+241.0%
The Coca-Cola Compa… (KO)100184.9+84.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: EQ vs KMDA vs JPM vs KO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: EQ and KMDA are tied at the top with 2 categories each — the right choice depends on your priorities. Kamada Ltd. is the stronger pick specifically for growth and revenue expansion and dividend income and shareholder returns. KO and JPM also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
EQ
Equillium, Inc.
The Defensive Pick

EQ has the current edge in this matchup, primarily because of its strength in sleep-well-at-night and defensive.

  • Lower volatility, beta 0.58, Low D/E 2.5%, current ratio 10.32x
  • Beta 0.58, current ratio 10.32x
  • Beta 0.58 vs KMDA's 1.28, lower leverage
  • +6.3% vs KMDA's +10.8%
Best for: sleep-well-at-night and defensive
KMDA
Kamada Ltd.
The Income Pick

KMDA is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.

  • Dividend streak 0 yrs, beta 1.28, yield 2.9%
  • Rev growth 12.1%, EPS growth 48.0%, 3Y rev CAGR 11.7%
  • 12.1% revenue growth vs EQ's -100.0%
  • 2.9% yield, vs KO's 2.5%, (1 stock pays no dividend)
Best for: income & stability and growth exposure
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM is the clearest fit if your priority is long-term compounding and valuation efficiency.

  • 465.8% 10Y total return vs KO's 121.1%
  • PEG 0.81 vs KO's 2.26
  • Lower P/E (14.4x vs 25.3x), PEG 0.81 vs 2.26
Best for: long-term compounding and valuation efficiency
KO
The Coca-Cola Company
The Quality Compounder

KO is the clearest fit if your priority is quality and efficiency.

  • 27.8% margin vs EQ's 2.6%
  • 13.1% ROA vs EQ's -53.7%, ROIC 15.8% vs -88.8%
Best for: quality and efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthKMDA logoKMDA12.1% revenue growth vs EQ's -100.0%
ValueJPM logoJPMLower P/E (14.4x vs 25.3x), PEG 0.81 vs 2.26
Quality / MarginsKO logoKO27.8% margin vs EQ's 2.6%
Stability / SafetyEQ logoEQBeta 0.58 vs KMDA's 1.28, lower leverage
DividendsKMDA logoKMDA2.9% yield, vs KO's 2.5%, (1 stock pays no dividend)
Momentum (1Y)EQ logoEQ+6.3% vs KMDA's +10.8%
Efficiency (ROA)KO logoKO13.1% ROA vs EQ's -53.7%, ROIC 15.8% vs -88.8%

EQ vs KMDA vs JPM vs KO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

EQEquillium, Inc.

Segment breakdown not available.

KMDAKamada Ltd.
FY 2025
Distribution Member
100.0%$24M
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000
KOThe Coca-Cola Company
FY 2025
Pacific
84.6%$31.6B
Bottling investments
15.4%$5.7B

EQ vs KMDA vs JPM vs KO — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLKOLAGGINGJPM

Income & Cash Flow (Last 12 Months)

KO leads this category, winning 4 of 6 comparable metrics.

JPM and EQ operate at a comparable scale, with $280.3B and $0 in trailing revenue. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to KMDA's 11.2%. On growth, KO holds the edge at +12.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricEQ logoEQEquillium, Inc.KMDA logoKMDAKamada Ltd.JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…
RevenueTrailing 12 months$0$182M$280.3B$49.3B
EBITDAEarnings before interest/tax-$20M$41M$81.4B$15.5B
Net IncomeAfter-tax profit-$19M$20M$57.0B$13.7B
Free Cash FlowCash after capex-$19M$17M$100.9B$12.6B
Gross MarginGross profit ÷ Revenue+41.2%+60.0%+61.7%
Operating MarginEBIT ÷ Revenue+14.0%+25.9%+29.3%
Net MarginNet income ÷ Revenue+11.2%+20.4%+27.8%
FCF MarginFCF ÷ Revenue+9.1%+36.0%+25.5%
Rev. Growth (YoY)Latest quarter vs prior year+2.8%+12.1%
EPS Growth (YoY)Latest quarter vs prior year+77.0%0.0%+16.0%+18.2%
KO leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Evenly matched — KMDA and JPM each lead in 3 of 7 comparable metrics.

At 16.0x trailing earnings, JPM trades at a 41% valuation discount to KO's 27.2x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs KO's 2.43x — a lower PEG means you pay less per unit of expected earnings growth.

MetricEQ logoEQEquillium, Inc.KMDA logoKMDAKamada Ltd.JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…
Market CapShares × price$271M$429M$896.0B$355.6B
Enterprise ValueMkt cap + debt − cash$241M$365M$1.50T$390.8B
Trailing P/EPrice ÷ TTM EPS-7.21x20.11x16.00x27.18x
Forward P/EPrice ÷ next-FY EPS est.17.40x14.40x25.27x
PEG RatioP/E ÷ EPS growth rate0.90x2.43x
EV / EBITDAEnterprise value multiple8.88x18.36x26.39x
Price / SalesMarket cap ÷ Revenue2.38x3.20x7.42x
Price / BookPrice ÷ Book value/share9.03x1.61x2.47x10.40x
Price / FCFMarket cap ÷ FCF25.34x8.88x67.15x
Evenly matched — KMDA and JPM each lead in 3 of 7 comparable metrics.

Profitability & Efficiency

KO leads this category, winning 5 of 9 comparable metrics.

KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-61 for EQ. EQ carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), KO scores 7/9 vs EQ's 1/9, reflecting strong financial health.

MetricEQ logoEQEquillium, Inc.KMDA logoKMDAKamada Ltd.JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…
ROE (TTM)Return on equity-61.4%+7.7%+15.9%+41.1%
ROA (TTM)Return on assets-53.7%+5.4%+1.3%+13.1%
ROICReturn on invested capital-88.8%+9.9%+4.5%+15.8%
ROCEReturn on capital employed-98.1%+8.0%+8.9%+17.3%
Piotroski ScoreFundamental quality 0–91657
Debt / EquityFinancial leverage0.03x0.04x2.60x1.33x
Net DebtTotal debt minus cash-$30M-$64M$599.0B$35.2B
Cash & Equiv.Liquid assets$30M$75M$343.3B$10.3B
Total DebtShort + long-term debt$719,000$12M$942.4B$45.5B
Interest CoverageEBIT ÷ Interest expense26.87x0.74x10.70x
KO leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

EQ leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $4,691 for EQ. Over the past 12 months, EQ leads with a +627.0% total return vs KMDA's +10.8%. The 3-year compound annual growth rate (CAGR) favors EQ at 58.2% vs KO's 13.7% — a key indicator of consistent wealth creation.

MetricEQ logoEQEquillium, Inc.KMDA logoKMDAKamada Ltd.JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…
YTD ReturnYear-to-date+83.7%+9.4%-0.5%+20.3%
1-Year ReturnPast 12 months+627.0%+10.8%+21.8%+17.2%
3-Year ReturnCumulative with dividends+295.8%+49.4%+138.2%+47.0%
5-Year ReturnCumulative with dividends-53.1%+33.7%+118.2%+65.6%
10-Year ReturnCumulative with dividends-79.9%+112.7%+465.8%+121.1%
CAGR (3Y)Annualised 3-year return+58.2%+14.3%+33.6%+13.7%
EQ leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

KO leads this category, winning 2 of 2 comparable metrics.

KO is the less volatile stock with a -0.20 beta — it tends to amplify market swings less than KMDA's 1.28 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 98.3% from its 52-week high vs KMDA's 79.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricEQ logoEQEquillium, Inc.KMDA logoKMDAKamada Ltd.JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…
Beta (5Y)Sensitivity to S&P 5000.58x1.28x0.94x-0.20x
52-Week HighHighest price in past year$3.43$9.35$337.25$84.04
52-Week LowLowest price in past year$0.27$6.50$262.71$65.35
% of 52W HighCurrent price vs 52-week peak+81.9%+79.6%+95.1%+98.3%
RSI (14)Momentum oscillator 0–10056.741.259.160.6
Avg Volume (50D)Average daily shares traded565K46K7.0M12.7M
KO leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — KMDA and KO each lead in 1 of 2 comparable metrics.

Analyst consensus: EQ as "Buy", KMDA as "Buy", JPM as "Buy", KO as "Buy". Consensus price targets imply 122.4% upside for EQ (target: $6) vs 4.2% for KO (target: $86). For income investors, KMDA offers the higher dividend yield at 2.88% vs JPM's 1.86%.

MetricEQ logoEQEquillium, Inc.KMDA logoKMDAKamada Ltd.JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$6.25$11.00$339.75$86.13
# AnalystsCovering analysts1266148
Dividend YieldAnnual dividend ÷ price+2.9%+1.9%+2.5%
Dividend StreakConsecutive years of raises01556
Dividend / ShareAnnual DPS$0.21$5.95$2.04
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+3.9%+0.2%
Evenly matched — KMDA and KO each lead in 1 of 2 comparable metrics.
Key Takeaway

KO leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EQ leads in 1 (Total Returns). 2 tied.

Best OverallThe Coca-Cola Company (KO)Leads 3 of 6 categories
Loading custom metrics...

EQ vs KMDA vs JPM vs KO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is EQ or KMDA or JPM or KO a better buy right now?

For growth investors, Kamada Ltd.

(KMDA) is the stronger pick with 12. 1% revenue growth year-over-year, versus -100. 0% for Equillium, Inc. (EQ). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Equillium, Inc. (EQ) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — EQ or KMDA or JPM or KO?

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 16. 0x versus The Coca-Cola Company at 27. 2x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus The Coca-Cola Company's 2. 26x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — EQ or KMDA or JPM or KO?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +118. 2%, compared to -53. 1% for Equillium, Inc. (EQ). Over 10 years, the gap is even starker: JPM returned +465. 8% versus EQ's -79. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — EQ or KMDA or JPM or KO?

By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.

20β versus Kamada Ltd. 's 1. 28β — meaning KMDA is approximately -742% more volatile than KO relative to the S&P 500. On balance sheet safety, Equillium, Inc. (EQ) carries a lower debt/equity ratio of 3% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — EQ or KMDA or JPM or KO?

By revenue growth (latest reported year), Kamada Ltd.

(KMDA) is pulling ahead at 12. 1% versus -100. 0% for Equillium, Inc. (EQ). On earnings-per-share growth, the picture is similar: Kamada Ltd. grew EPS 48. 0% year-over-year, compared to -69. 6% for Equillium, Inc.. Over a 3-year CAGR, KMDA leads at 11. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — EQ or KMDA or JPM or KO?

The Coca-Cola Company (KO) is the more profitable company, earning 27.

3% net margin versus 0. 0% for Equillium, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus 0. 0% for EQ. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is EQ or KMDA or JPM or KO more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus The Coca-Cola Company's 2. 26x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 4x forward P/E versus 25. 3x for The Coca-Cola Company — 10. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EQ: 122. 4% to $6. 25.

08

Which pays a better dividend — EQ or KMDA or JPM or KO?

In this comparison, KMDA (2.

9% yield), KO (2. 5% yield), JPM (1. 9% yield) pay a dividend. EQ does not pay a meaningful dividend and should not be held primarily for income.

09

Is EQ or KMDA or JPM or KO better for a retirement portfolio?

For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

20), 2. 5% yield, +121. 1% 10Y return). Both have compounded well over 10 years (KO: +121. 1%, EQ: -79. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between EQ and KMDA and JPM and KO?

These companies operate in different sectors (EQ (Healthcare) and KMDA (Healthcare) and JPM (Financial Services) and KO (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: EQ is a small-cap quality compounder stock; KMDA is a small-cap quality compounder stock; JPM is a large-cap deep-value stock; KO is a large-cap quality compounder stock. KMDA, JPM, KO pay a dividend while EQ does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.